Efficacy and safety of obinutuzumab + lenalidomide + atezolizumab in patients with relapsed or refractory follicular lymphoma: Primary analysis of a phase 1b/2 trial Meeting Abstract
| Authors: | Morschhauser, F.; Ghosh, N.; Lossos, I.; Palomba, M. L.; Mehta, A.; Casasnovas, O.; Stevens, D.; Chitra, S.; Knapp, A.; Nielsen, T.; Oestergaard, M.; Wenger, M.; Salles, G. |
| Abstract Title: | Efficacy and safety of obinutuzumab + lenalidomide + atezolizumab in patients with relapsed or refractory follicular lymphoma: Primary analysis of a phase 1b/2 trial |
| Meeting Title: | 15th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 37 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Jun 18-22 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-06-01 |
| Start Page: | 113 |
| End Page: | 114 |
| Language: | English |
| ACCESSION: | 137029480 |
| DOI: | 10.1002/hon.74_2629 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| PUBMED: | 31187525 |
| DOI/URL: | |
| Notes: | Meeting Abstract: O68 -- Source: cin20 |
